Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01954576 · ClinicalTrials.gov registry record · NA
NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
A NA study, sponsored by University of Florida.
- Terminated
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT01954576 is a NA study that was terminated before completion, run by University of Florida. The registered enrollment target is 21 participants.
The verdict
NCT01954576, a NA study, was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
This pilot phase II trial studies how well Novocure's Tumor Treating Electric Fields (NovoTTF) therapy works in treating patients with recurrent glioblastoma multiforme. NovoTTF therapy uses a low intensity electric current to kill tumor cells. NovoTTF therapy may be effective treatment for brain cancer.
Interventions
- PROCEDURE Quality-of-life assessment
- DEVICE NovoTTF-100A
- GENETIC Laboratory biomarker analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2013-10-10 |
| Est. Completion | 2021-05-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01954576
The ClinicalTrials.gov registry entry for NCT01954576 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Quality-of-life assessment is the first listed.
NCT01954576 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01954576 about?
NCT01954576 is a clinical study titled "NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme". This pilot phase II trial studies how well Novocure's Tumor Treating Electric Fields (NovoTTF) therapy works in treating patients with recurrent glioblastoma multiforme. NovoTTF therapy uses a low intensity electric current to kill tumor cells. NovoTTF therapy may be effective treatment for brain ca...
What is the current status of trial NCT01954576?
This trial is currently terminated. It is a NA study. The enrollment target is 21 participants. The study started on 2013-10-10. Estimated completion is 2021-05-14.
What interventions are being tested in trial NCT01954576?
The interventions under investigation include: Quality-of-life assessment (PROCEDURE), NovoTTF-100A (DEVICE), Laboratory biomarker analysis (GENETIC).
Who is sponsoring clinical trial NCT01954576?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.